Skip to main content
. 2021 Apr 25;23(10):1612–1676. doi: 10.1093/europace/euab065

Figure 4.

Figure 4

Switching between NOACs and other anticoagulants. ACS, acute coronary syndrome; BID, twice daily; INR, international normalized ratio; LMWH, low molecular weight heparin; NOAC, non-vitamin K antagonist oral anticoagulant; QD, once daily; UFH, unfractionated heparin; VKA, vitamin K antagonist.